The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Imo all safety studies should be duplicated, with one run by someone that wants the study to give a safe and effective conclusion and another run by someone who wants the study to give a dangerous or ineffective conclusion. Both studies monitored by neutral parties that are rewarded based on how long the studies stand up for. And no NDAs (or at least no NDAs that don’t expire once the product hits the market) so that all three can be vocal about any issues they had with how the others wanted things run.
History and the motivation to make money say you’re spot on. Despite that, I’m still happy to be opening up new pathways for pain reduction. I’m hoping for the best for this and other options.
10000% there are side effects that they know about and will hide. I’m willing to place my honor as a gentleman on the line.
Imo all safety studies should be duplicated, with one run by someone that wants the study to give a safe and effective conclusion and another run by someone who wants the study to give a dangerous or ineffective conclusion. Both studies monitored by neutral parties that are rewarded based on how long the studies stand up for. And no NDAs (or at least no NDAs that don’t expire once the product hits the market) so that all three can be vocal about any issues they had with how the others wanted things run.
And criminal charges for any kind of corruption.
There will be whigs on the lawn I say!
History and the motivation to make money say you’re spot on. Despite that, I’m still happy to be opening up new pathways for pain reduction. I’m hoping for the best for this and other options.